98%
921
2 minutes
20
Gastrointestinal subepithelial tumors (SETs), including neoplastic and non-neoplastic lesions, often require resection when symptomatic or when they possess malignant potential. Endoscopic full-thickness resection (EFTR) and submucosal tunnel endoscopic resection (STER) are minimally invasive techniques used for resecting these lesions. This meta-analysis aims to compare the efficacy and safety of EFTR and STER in the treatment of upper gastrointestinal (GI) lesions. A systematic search was conducted in Embase, Scopus, Web of Science, Medline/PubMed, and Cochrane databases up to August 2024. Studies comparing EFTR and STER for upper GI lesions were included. Outcomes assessed were en bloc resection rate, complete resection rate, procedure time, recurrence rate, hospital stay, perforation rate, bleeding, and follow-up duration. Data were pooled using a random-effects model, and statistical significance was set at P <0.05. Eight studies, including 725 patients, were included. EFTR showed a significantly higher en-bloc resection rate (OR=4.81, 95% CI=1.56-14.90, P =0.006) and complete resection rate (OR=3.58, 95% CI=1.19-10.76, P =0.02). Recurrence rates were lower with EFTR (OR=0.17, 95% CI=0.03-0.87, P =0.03). No significant differences were found between EFTR and STER in procedure time (MD=-6.50 min, P =0.06), perforation rate (OR=9.38, P =0.41), or bleeding rates (OR=0.72, P =0.20). EFTR was associated with a shorter hospital stay (MD=0.66 d, 95% CI=0.27-1.05). EFTR offers superior en-bloc and complete resection rates, and a lower recurrence rate compared with STER for upper GI lesions. Both techniques are comparable in terms of procedure time and adverse events, with EFTR offering shorter hospital stays. However, the choice between EFTR and STER should be guided by tumor characteristics (size and location), endoscopist experience, and institutional resources. Further multicenter randomized studies are needed to confirm these findings and address variability in perforation risk.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MCG.0000000000002233 | DOI Listing |
Am J Clin Pathol
September 2025
Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
Objective: Choline transporter (ChT) immunohistochemistry (IHC) is a new ancillary test that aids in the diagnosis of Hirschsprung disease in newborns and infants. The behavior of this stain in older children (greater than 1 year of age) with chronic constipation, where Hirschsprung disease is clinically unlikely, has not been investigated. The aim of our study was to determine the behavior of ChT IHC in rectal biopsies performed on older children with chronic constipation.
View Article and Find Full Text PDFSurg Endosc
September 2025
Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
Background And Aims: Traditional endoscopic full-thickness resection (EFTR) involves complete removal of the lesion followed by defect closure. The separated resection and closure technique results in mucosal eversion and misalignment of the muscularis propria layers, making reliable closure difficult. Here, we developed an innovative "cut-and-seal-as-you-go" technique, "Zipper-EFTR" and evaluated the feasibility and safety of the new technique.
View Article and Find Full Text PDFEndoscopy
December 2025
Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine Graduate School of Medicine, Yokohama, Japan.
Dig Dis Sci
September 2025
Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Zhengzhou, 450052, Henan, China.
Endoscopy
December 2025
Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, China.